Watch Ticker

Cytokinetics Inc.

Go to Cytokinetics Inc. Website

$36.16

-0.42 (-1.15%)

Live

Previous Close

$36.58

Day Range

$35.63 - $36.5847

Previous Day Range

$35.86 - $36.77

Market Cap

$4.4 billion USD

Day Vol.

1.2 million

Previous Day Vol.

1.6 million

Currency

USD

Primary Exchange

Nasdaq

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle p...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Cytokinetics, a biopharmaceutical company, announced that it granted stock options and restricted stock units to 11 new employees as a material inducement to their employment. The awards are subject to the company's equity incentive plan and vesting schedules.

Related tickers: CYTK.

Read Full Article

Cytokinetics, Incorporated - Cytokinetics Presents Additional Data Related to Aficamten at the European Society of Cardiology Heart Failure 2025 Congress

Cytokinetics presented additional data from the SEQUOIA-HCM trial on the efficacy of aficamten in patients with obstructive hypertrophic cardiomyopathy, as well as real-world data on disparities in outcomes for females and older patients with non-obstructive HCM.

Related tickers: CYTK.

Read Full Article

Trending Tickers

Please sign in to view